Explore the full record of transactions filed by PERRY MICHAEL S, Director. Officer active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 14 disclosures have been published. Total volume traded: €2.7m. The latest transaction was filed on 5 December 2025 — Cession. Regulator: SEC (Form 4). The full history is openly available.
PERRY MICHAEL S serves as Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC. and AVITA Medical, Inc. He oversees the overall operations and strategy of these companies, focusing on innovation in the healthcare sector. With extensive experience in the biopharmaceutical industry, he is responsible for guiding teams towards achieving strategic objectives and maximizing shareholder value. His leadership is essential for navigating a competitive environment.